APA (7th ed.) Citation

Westphal, M., & Geletneky, K. (2015). A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma. European journal of cancer, 51(4), . https://doi.org/10.1016/j.ejca.2014.12.019

Chicago Style (17th ed.) Citation

Westphal, Manfred, and Karsten Geletneky. "A Randomised, Open Label Phase III Trial with Nimotuzumab, an Anti-epidermal Growth Factor Receptor Monoclonal Antibody in the Treatment of Newly Diagnosed Adult Glioblastoma." European Journal of Cancer 51, no. 4 (2015). https://doi.org/10.1016/j.ejca.2014.12.019.

MLA (9th ed.) Citation

Westphal, Manfred, and Karsten Geletneky. "A Randomised, Open Label Phase III Trial with Nimotuzumab, an Anti-epidermal Growth Factor Receptor Monoclonal Antibody in the Treatment of Newly Diagnosed Adult Glioblastoma." European Journal of Cancer, vol. 51, no. 4, 2015, https://doi.org/10.1016/j.ejca.2014.12.019.